Navigation Links
Annals colonoscopy study underscores importance of quality standards
Date:12/17/2008

A study by Baxter, et al. released this week and scheduled to be published in the Jan. 6, 2009, edition of Annals of Internal Medicine, concluded that while screening colonoscopy is associated with fewer deaths from colorectal cancer, the association is primarily limited to deaths from cancer developing in the left side of the colon.

This confirms the value of colonoscopy as a screening test and clarifies a possible weakness: detecting polyps on the right side of the colon. While the findings were notable, it's important to note that the study enrolled patients starting more than a decade ago. During the past decade, there have been significant advances in how colonoscopies are performed and in the colonoscopes themselves with wider fields of view and better optics.

"It's of paramount importance that physicians perform a colonoscopy examination as effectively as possible," notes Robert Sandler, MD, AGAF, president of the AGA Institute. "Gastroenterologists are aware of the need to slowly withdraw the colonoscope and to carefully examine the right colon for flat polyps. The most important variable in colonoscopy is the skill of the physician performing the test. Having a well trained, careful endoscopist who is aware of the newest ideas and techniques is a patient's best protection against poor results."

The AGA and other professional societies are working to make quality care a priority for the medical community. To define high-quality colonoscopy, the AGA directs physicians, purchasers and the public to the standards for endoscopy and polyp surveillance created by the AGA and ASGE through the Physician Consortium for Performance Improvement and the National Committee for Quality Assurance. We urge all who perform colonoscopy to adhere to this physician performance measure set.

Of par
'/>"/>

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. July/August 2008 Annals of Family Medicine tip sheet
2. Annals of Internal Medicine tip sheet for May 20, 2008, issue
3. May/June 2008 Annals of Family Medicine tip sheet
4. Tip sheet for the Annals of Internal Medicine, April 15, 2008, issue
5. Annals of Internal Medicine tip sheet for April 1, 2008, issue
6. Annals of Internal Medicine tip sheet for Feb. 5, 2008, issue
7. Annals of Internal Medicine tip sheet for Jan. 1, 2008, issue
8. Annals of Internal Medicine Tip Sheet for Nov. 20, 2007, Issue
9. Annals of Internal Medicine tip sheet for Oct. 2
10. September/October 2007 Annals of Family Medicine tip sheet
11. Annals of Internal Medicine tip sheet for Aug. 21, 2007, issue

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... announced that it has become a national sponsor o...profit organizations dedicated to arthritis resear... Delray Beach, FL (Vocus) November 27, 200...any specializing in the marketing and retail distr...nced today that is has become a national sponsor o...
(Date:11/27/2009)...conomic burdens, study predicts , , FRID...le with diabetes in the United States is expected ...icts. , That would bring the total by 2034 to a... 23.7 million today. , , At the same time, the c...the study also warns, rising from an estimated $11...
(Date:11/27/2009)...announced today that Spectrum Health (Grand Rapids...orthopedic templating solution and its TraumaCad E... (PRWEB) November 27, 2009 -- Voyant Health&trade...ds, Michigan) has licensed its TraumaCad Enterpris... Extend workflow solution, to allow its orthopedic...
(Date:11/27/2009)...ers who use medical load cells at the heart of the...ging in technology partner Flintec early in the de...ical manufacturers are calling in Flintec load cel...ensuring that progress will not be constrained by ...technology. , (PRWEB) Nov...
(Date:11/26/2009)...fluseasonuponus,it,smoreimportantthanevertoemployg...illness. ,, "Weneedtobeproactivenotonlytokeepou...esick,"saidEileenFinerty,RN,MS,CIC(certifiedininfe...ndoccupationalhealthatHospitalforSpecialSurgery(HS...neofthelowestinfectionratesofanyhospitalinthecount...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3
...ELPHIA (January 22, 2008) -- Researchers from the ...have used a novel molecular method to identify che...man bitter taste receptors. , The findings, publ...ste in particular. , Identification of bitter t...
...chers in the Department of Medicine and Department...e have discovered that chronic pain can be success... an effort to find a more effective treatment for ...ensory neuron targeting by self-complementary AAV8...
...da, MD (Jan. 18, 2008) The use of regular, long-t...ugs (NSAIDs) reduces the risk associated with colo...Gastroenterology , the official journal of the Ame... at doses that are higher than recommended over a ...
...l, January 22, 2007 An international research tea...de lUniversit de Montral (CHUM), has identified ne...e sclerosis (MS). In the February issue of Nature ... the nervous system that affects approximately 55,...
...dies sense painful stimuli through certain recepto...l organs. Specialized nerve fibers relay these sig... pain becomes conscious. The spinal cord is placed...nd at the Institute of Pharmacology and Toxicology...
...taking Nexavar need to be monitored closely, study...) -- ,A drug that prolongs the lives of patients w... of developing high blood pressure. , Patients ta...logy . , Nexavar is an anti-angiogenesis drug, mea...
Other Medicine News:Health News:Food peptides activate bitter taste receptors 2Health News:Researchers find relief for chronic pain 2Health News:Regular, long-term aspirin use reduces risk of colorectal cancer 2Health News:New therapeutic target for treatment of multiple sclerosis 2Health News:Nature publication on pain research 2Health News:Liver Cancer Drug Raises Blood Pressure 2
(Date:11/25/2009)...Calif.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,ann...ny,sPROTECT-1(theProspectiveRandomizedOralTherapyE...CX282-B)inpatientswithmoderate-to-severeCrohn,sdis...tyandtolerabilityprofile.Thestudydemonstratedevide...tyasdefinedasa70-pointdecreaseintheCrohn,sDiseaseA...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--Endologix,Inc.(Nasd...oraorticdisorders,announcedtodaythatithasfiledamot...nfringementlawsuitbroughtagainstitinOctober2009byC...CourtinIndianapolis,Indiana. ,, Endologixhasreq...sPatentandTrademarkOffice(USPTO)conductsproceeding...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--AnadysPharmaceuticals,In...the21stAnnualPiperJaffrayHealthcareConferenceonTue...onferenceisbeingheldatTheNewYorkPalaceHotel.SteveW...adys,willprovideanoverviewofAnadysanditsclinicalde...atepresentationwillbesimultaneouslywebcastandcanbe...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2AMT Provides Business Update for the Third Quarter 2009 14895 1AMT Provides Business Update for the Third Quarter 2009 14895 2AMT Provides Business Update for the Third Quarter 2009 14895 3AMT Provides Business Update for the Third Quarter 2009 14895 45 exercises can reduce neck shoulder pain of women office workers 10780 15 exercises can reduce neck shoulder pain of women office workers 10780 25 exercises can reduce neck shoulder pain of women office workers 10780 3BioSoteria CEO to Present at Drug Safety Conference 14889 1BioSoteria CEO to Present at Drug Safety Conference 14889 2
...ENEVA, April 20, 2007 /PRNewswire/ -- Addex Pharma...n of a Phase IIa proof of,concept trial with its l...he study achieved its primary objective, the absen...al significance, and,also showed trends towards im...igraine pain at other time points. ADX10059 has,al...
...ATTLE--(BUSINESS WIRE)--Apr 19, 2007 - Gilead Scie...results of its Phase III,AIR-CF2 study evaluating ... patients with cystic fibrosis (CF) who have,pulmo...e study, a,28-day treatment course of aztreonam ly...nhaled or intravenous (IV) antibiotics versus,plac...
Other Medicine Technology:Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 2Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 3Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7
Atria 3100 ECG
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
...es is a national reference laboratory and a worldw...evelopment. ARUP offers an extensive test menu of ...l and anatomic pathology. Owned by the University ...han half of the nation's university teaching hospi...
Medicine Products: